Technology | Magnetic Resonance Imaging (MRI) | October 24, 2017

Esaote Launches Q-Spine Analysis Software

Software for Brio G MRI scanner allows enhanced numerical analysis of weight-bearing versus recumbent spinal MRI exams

Esaote Launches Q-Spine Analysis Software

October 24, 2017 — Esaote will launch Q-Spine, a technology that provides biometrics of the spine, at the North America Spine Society (NASS) annual meeting, Oct. 25–28 in Orlando, Fla. Q-Spine is a software tool to assist spine surgeons, orthopedists and chiropractors in their planning therapy and surgical procedures by means of visualization and quantification of relative biomechanical changes between weight-bearing and recumbent magnetic resonance imaging (MRI) lumbar spine examination.

Also at NASS 2017, Richard D. Guyer, M.D., from the Texas Back Institute will present an abstract titled on Q-Spine titled “Q-Spine: New MRI-Based Quantification Method for L-Spine Analysis,” during the Innovative Technology Presentations.

Q-Spine facilitates and simplifies the analysis of weight-bearing versus recumbent MRI through semi-automatic segmentation of the Lumbar-spine. The system provides a numerical quantification of the relative changes, establishing reliable and coherent measures by taking out the “human factor.” It provides the ability to evaluate patient follow-up with numerical evidence, and generates a PDF report to be attached to the medical report

Guyer stated, “We are excited to present the Q-Spine software, which is a semi-automated software analysis used with the Esaote weight-bearing Brio G MRI scanner, which reliably calculates spinal canal area, dural diameter, lumbar lordosis and sacral angles. We believe this will demonstrate nerve compression which may not be diagnosed with supine MRI scanners and help surgeons manage sagittal alignment in their patients.”

Q-Spine is available on Esaote’s G-Scan Brio, a dedicated MRI system featuring a comprehensive set of coils and sequences to provide complete musculoskeletal (MSK) MRI, from spine to extremities — plus the ability to perform unique weight-bearing studies.

For more information: www.esaote.com

Related Content

ADHD Medication May Affect Brain Development in Children

Images of regions of interest (colored lines) in the white matter skeleton representation. Data from left and right anterior thalamic radiation (ATR) were averaged. Image courtesy of C. Bouziane et al.

News | Neuro Imaging | August 16, 2019
A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
Synaptive Medical Launches Modus Plan With Automated Tractography Segmentation
Technology | Neuro Imaging | August 07, 2019
Synaptive Medical announced the U.S. launch and availability of Modus Plan featuring BrightMatter AutoSeg. This release...
Canon Medical Introduces Encore Orian MR Upgrade Program
News | Magnetic Resonance Imaging (MRI) | August 06, 2019
Canon Medical Systems USA Inc. is helping to provide low-cost patient care solutions for its customers with the launch...
FDA Issues Draft Guidance on Medical Device Safety in MRI Environment
News | Magnetic Resonance Imaging (MRI) | August 01, 2019 | Jeff Zagoudis, Associate Editor
The U.S. Food and Drug Administration (FDA) issued a new draft guidance titled Testing and Labeling Medical Devices for...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...